Tag: Valneva
Valneva plummets after bad news about its Lyme disease vaccine candidate
(Boursier.com) — Valneva fall of almost 10% this Friday, back to 5.75 euros, while Pfizer And Valneva announced that Pfizer, as the study sponsor, has decided to exclude a significant…
Valneva: FDA grants priority review to chikungunya vaccine candidate – 02/20/2023 at 09:51
(AOF) – Valneva, a company specializing in vaccines, announces today that the American health authority, Food and Drug Administration (FDA), has completed the review of the admissibility of the application…
Valneva falls, Lyme disease vaccine trials disrupted
Published on 02/17/2023 at 1:42 p.m. Photo credit © Reuters PARIS (Reuters) – Valneva fell on…
Valneva: FDA priority review in chikungunya
(CercleFinance.com) – Valneva announces that the US FDA has successfully completed the admissibility review of its marketing authorization application for its single-shot chikungunya vaccine candidate. The United States health authority…
Valneva: Plagued by disruptions in its Lyme disease trials, Valneva falls on the stock market
(BFM Bourse) – This setback on its vaccine against Lyme disease is more bad news for Valneva, which announced the day before that it was expecting a drop in sales…
Valneva: In fall for a disturbed study in Lyme
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
Valneva in fall for a disturbed study in Lyme – 02/17/2023 at 17:00
(CercleFinance.com) – Valneva drops by almost 7%, after the decision of its partner Pfizer to interrupt a significant percentage of participants in the United States enrolled in the phase 3…
Abnormal volumes in Paris today: Eutelsat Com., Valneva
During this trading session on Friday February 17, 2023, abnormal trading volumes were detected on the French market. Today is the Eutelsat Com share. which stands out, with exchanges up…
Valneva: new mixed data in Covid-19 – 01/02/2023 at 07:50
(CercleFinance.com) – Valneva announced, at the very end of last week, the publication of new mixed data from a small exploratory study on the use as a heterologous booster of…
Valneva: New mixed data in Covid-19
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
Valneva: publication of new data against Covid-19 – 01/02/2023 at 08:48
(AOF) – Valneva has announced the publication of new data from a small exploratory study on the use as a heterologous booster of its inactivated vaccine against Covid-19, VLA2001. In…
Valneva: new mixed data in Covid-19
(CercleFinance.com) – Valneva announced, at the very end of last week, the publication of new mixed data from a small exploratory study on the use as a heterologous booster of…